Identification of Potent Ras Signaling Inhibitors by Pathway‐Selective Phenotype‐Based Screening
- 14 January 2004
- journal article
- zuschrift
- Published by Wiley in Angewandte Chemie
- Vol. 116 (4), 456-460
- https://doi.org/10.1002/ange.200352587
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Sulindac‐Derived Ras Pathway Inhibitors Target the Ras–Raf Interaction and Downstream Effectors in the Ras PathwayAngewandte Chemie International Edition, 2004
- Sulindac‐Derived Ras Pathway Inhibitors Target the Ras–Raf Interaction and Downstream Effectors in the Ras PathwayAngewandte Chemie, 2004
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- Exisulind, a selective apoptotic antineoplastic drugExpert Opinion on Investigational Drugs, 2001
- Ras—A Molecular Switch Involved in Tumor FormationPublished by Wiley ,2000
- Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based ScreenScience, 1999
- Sulindac sulfide inhibits Ras signalingOncogene, 1998
- Preparation of Acrylophenones and 2-Alkyl Indanones Utilizing Hexamethylenetetramine as an Inexpensive Mannich Reagent.Synthetic Communications, 1996
- Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl.The Journal of Experimental Medicine, 1995
- Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonistsJournal of Medicinal Chemistry, 1988